Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1948 1
1951 1
1952 2
1953 1
1956 2
1959 1
1960 1
1962 3
1963 3
1964 5
1965 1
1966 3
1967 1
1968 9
1969 3
1970 1
1971 3
1972 3
1973 2
1974 5
1975 2
1976 5
1977 1
1978 2
1979 6
1980 4
1981 2
1982 9
1983 12
1984 5
1985 11
1986 8
1987 11
1988 9
1989 9
1990 12
1991 10
1992 18
1993 18
1994 16
1995 25
1996 23
1997 28
1998 24
1999 25
2000 26
2001 33
2002 40
2003 37
2004 49
2005 65
2006 63
2007 72
2008 56
2009 64
2010 70
2011 78
2012 94
2013 74
2014 65
2015 69
2016 73
2017 75
2018 80
2019 68
2020 111
2021 112
2022 96
2023 104
2024 42

Text availability

Article attribute

Article type

Publication date

Search Results

1,862 results

Results by year

Filters applied: . Clear all
Page 1
A two-dose viral-vectored Plasmodium vivax multistage vaccine confers durable protection and transmission-blockade in a pre-clinical study.
Yamamoto Y, Fabbri C, Okuhara D, Takagi R, Kawabata Y, Katayama T, Iyori M, Hasyim AA, Sakamoto A, Mizukami H, Shida H, Lopes S, Yoshida S. Yamamoto Y, et al. Among authors: sakamoto a. Front Immunol. 2024 Apr 30;15:1372584. doi: 10.3389/fimmu.2024.1372584. eCollection 2024. Front Immunol. 2024. PMID: 38745665 Free PMC article.
Diagnostic delay of MYH9-related disorder in Japan.
Sakamoto A, Uchiyama T, Kaname T, Iguchi A, Ohara O, Ishimura M, Onum M, Kunishima S, Ishiguro A. Sakamoto A, et al. Br J Haematol. 2024 Apr 22. doi: 10.1111/bjh.19484. Online ahead of print. Br J Haematol. 2024. PMID: 38650331
Engineering CD3/CD137 Dual Specificity into a DLL3-Targeted T-Cell Engager Enhances T-Cell Infiltration and Efficacy against Small-Cell Lung Cancer.
Mikami H, Feng S, Matsuda Y, Ishii S, Naoi S, Azuma Y, Nagano H, Asanuma K, Kayukawa Y, Tsunenari T, Kamikawaji S, Iwabuchi R, Shinozuka J, Yamazaki M, Kuroi H, Ho SSW, Gan SW, Chichili P, Pang CL, Yeo CY, Shimizu S, Hironiwa N, Kinoshita Y, Shimizu Y, Sakamoto A, Muraoka M, Takahashi N, Kawa T, Shiraiwa H, Mimoto F, Kashima K, Kamata-Sakurai M, Ishikawa S, Aburatani H, Kitazawa T, Igawa T. Mikami H, et al. Among authors: sakamoto a. Cancer Immunol Res. 2024 Apr 1:OF1-OF12. doi: 10.1158/2326-6066.CIR-23-0638. Online ahead of print. Cancer Immunol Res. 2024. PMID: 38563577
Engineering CD3/CD137 dual specificity into a DLL3-targeted T-cell engager enhances T-cell infiltration and efficacy against small cell lung cancer.
Mikami H, Feng S, Matsuda Y, Ishii S, Naoi S, Azuma Y, Nagano H, Asanuma K, Kayukawa Y, Tsunenari T, Kamikawaji S, Iwabuchi R, Shinozuka J, Yamazaki M, Kuroi H, Ho SSW, Gan SW, Chichili P, Pang CL, Yeo CY, Shimizu S, Hironiwa N, Kinoshita Y, Shimizu Y, Sakamoto A, Muraoka M, Takahashi N, Kawa T, Shiraiwa H, Mimoto F, Kashima K, Kamata-Sakurai M, Ishikawa S, Aburatani H, Kitazawa T, Igawa T. Mikami H, et al. Among authors: sakamoto a. Cancer Immunol Res. 2024 Mar 20. doi: 10.1158/2326-6066.CIR-23-0638. Online ahead of print. Cancer Immunol Res. 2024. PMID: 38558120
1,862 results